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I~  Increasing levels of precipitating antibodies to Achromobacter 
xylosoxidans and Burkholderia multivorans reflect more 
aggressive pulmonary disease in chronically infected 
Cystic Fibrosis patients 
B. Bugge 1, T. Pressler 1 , H.K. Johansen 2, K.G. Nielsen 1, N. Hoiby 2. 1pulm 
Service & @stic Fibrosis' Cente~ Dept of Paediatrics, 2Dept of Microbiology, 
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Introduction; Absolute level and rapidly increasing levels of precipitating anti- 
bodies to Pseudomonas eruginosa (PA) in chronic pulmonary infection in cystic 
fibrosis (CF) are correlated with degree of lung inflammation, tissue damage and 
poor prognosis. Precipitating antibodies to other Gram-negative bacteria may exhibit 
similar properties. 
Aims; To assess the correlation between levels of precipitins to Achromobacter 
xylosoxidans (AX), and Burkholderia multivorans iBM) and lung function in 
chronically infected CF patients. 
Methods: All patients with a diagnosis of chronic infection with either AX or BM 
as per 2005 were included. The correlation between level of precipitating antibodies 
and FEV1% predicted was assessed. 
Results; 14 patients with chronic AX had median (range) FEV1% predicted of 66% 
(23 to 111%) and precipitin levels of 25 (3 to 40) showing statistically significant, 
but weak, negative correlation (r2 0.24, p < 0.05). Correspondingly, in 12 patients 
with chronic BM a statistically significant negative correlation (r2 0.65, p < 0.05) 
was shown between lung function: 63% (40 to 110%) and precipitin levels: 17 (8 
to 25). 
Conclusion: Chronic infection with AX or BM, like PA, induces increasing levels 
of precipitins as markers of enhanced tissue damage as reflected in declining 
lung function. Precipitins to other Gram-negative bacteria than PA may function 
as markers of infection severity, treatment success or failure. 
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Dynamics of the Staphylococcus aureus nasal carriage and upper 
airway colonization/infection in young Cystic Fibrosis patients 
S. Ridder-Schaphorn 1 , C. Breitkopf 1 , B. Ritzerfeld 1 , A. Dtibbers 2, J. H~iberle 2,
S. Falk 2 , R Kiister 3, A. Schuster 4 , E Ratjen 5, U. Mellies 5, B. L6we 6, R. Reintj es 6, 
G. Peters 1 , B.C. Kahl 1 . 1Med. Microbiology, 2Dept. Pediatrics, University Hos T. 
Muenste~ 3Clemenshosp. Muenster; 4 University Hosp., Duesseldorf;; 5Essen; 
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Aims: Nasal S. aureus carriage in cystic fibrosis (CF) patients might represent a 
risk factor for subsequent colonisation and infection of the upper and lower airways. 
Methods: Nasal (n 590) and throat swabs (n 901) or sputum (n 87) of 63 CF 
children younger than six years (median age 3.6 years) followed for at least 18 to 
24 months, were evaluated. 109 healthy children served as a control (median age 
1.6 years). Clonal identity of S. aureus trains was determined by pulsed-field gel 
electrophoresis. 
Results: S. aureus was cultured in 22/63 CF children (35%) from the anterior 
nares or in 30/63 (48%) from the throat at the first visit. Nasal and throat carriage 
of the control group was 18% (20/109), respectively. 16 CF children never carried 
S. aureus in their nares, 2 children ever in their throat. Most patients were colonized 
in throat and nose when recruited to the study (28/63). In 6 patients, initially the 
nose was colonized followed by the throat, whereas in 14 patients, the first S. aureus 
isolates were cultured from the throat later followed by the nose. 
Conclusions: The prevalence ofboth, nasal and throat colonization, in CF children 
was statistically significantly higher than in healthy children (p < 0.05). A subset of 
patients with nasal colonization might benefit from eradication procedures of nasal 
S. aureus carriage by topical mupirocin. 
This study was funded by the German Mukoviszidose .V, project F04/03. 
[ ]  Exopolysaccharide production in the Burkholderia cepacia in 
response to growth on onion agar 
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Aims: To investigate phenotypic responses to growth of the Burkholderia cepacia 
complex (Bcc) on agar medium containing onion extract. 
Methods: A panel of Bcc strains was cultured for 4 days at 30°C on bacterio- 
logical agar containing homogenised onion extract as the sole nutrient. Bacterial 
exopolysacharide (EPS) was extracted and analysed for similarity to the previously 
described Bcc EPS, Cepacian. SDS-PAGE analysis, ethyl acetate partition, paper 
electrophoresis, mass spectrometry and NMR were used to investigate he causative 
factor in the onion extract. 
Results: Unexpectedly, around 50% of previously "nonmucoid" Bcc strains pro- 
duced a copious mucoid colonial phenotype on onion agar. The degree of mucoidy 
was particularly striking in B. cepacia strain ATCC 25416, which was used for 
further study. Results of SDS-PAGE analysis, heat-treatment and reverse-phase 
chromatography suggest hat the causative agent is not a protein. We suspect 
that paper electrophoresis will identify the agent to be a carbohydrate. Further 
characterisation is planned by mass spectrometry and NMR. 
Conclusion: EPS production has been suggested as a potential virulence determi- 
nant in Bcc lung infection. Induction of EPS in the presence of"plant host extract" 
highlights the metabolic potential of the Bcc, and the ability of host factors to 
induce a phenotype which would be missed on routine culture. EPS production in 
Bcc may play a role in the pathogenesis of CF lung disease, similar to alginate in 
Pseudomonas eruginosa. As the natural host, the onion model could also provide 
novel insights into the regulation and biosynthesis of virulence determinants in the 
Bcc. 
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Aminosides are hydrophilic antibiotics. Loss of fat mass, a frequent occurrence in
cystic fibrosis, thus corresponds to greater diffusion. This study investigated the 
influence of the mode used to calculate the dose, in kilograms of total body weight 
or lean body mass, on the accuracy of the expected serum concentration. 
During 32 courses of antibiotic therapy in 16 patients, 10 girls and 6 boys with ages 
ranging from 9 to 26 years and weights ranging from 18 to 58 kg, 32 measurements 
of peak serum concentration f aminoside were coupled to measures of lean body 
mass. Tobramycin was used in 29 cases at a dose of 12 2 mg/kg of total body weight 
and amikacin was used in the other 3 cases, also at a dose of 22±6 mg/kg of total 
body weight; both were administered once daily. Aminoside was given by a 30-rain 
intravenous infusion and blood was drawn for peak serum concentration 30 minutes 
later. Lean body mass was assessed at the same time by measuring the impedance 
values with the Bodystat ®QuadScan 4000. 
The antibiotic serum concentrations were closely correlated with the dose expressed 
as kg of total body weight (r 0.75) and kg of lean body mass (r 0.81). The 
differences between the theoretical concentrations, calculated from the regressions 
established for the doses expressed in kg of total body weight and kg of lean body 
mass, and the real concentrations were greater, in 21 cases out of the 32, when the 
dose was expressed in kg of total body weight han when expressed as kg of lean 
body mass (p < 0.05). 
The determination f body composition can be useful for more precise calculation 
of the correct dose of aminosides for patients with cystic fibrosis. 
